Literature DB >> 29661109

Prevalence and Risk Factors for Methicillin-Resistant Staphylococcus aureus (MRSA) Infections in Custodial Populations: A Systematic Review.

Leigh Haysom1, Melanie Cross2, Rebecca Anastasas2, Elizabeth Moore1, Stephen Hampton3.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) in prisons can result in serious morbidity and death. We reviewed rates and risk factors for MRSA infection in custody, searching Medline, EMBASE, and CINAHL databases. Between 1997 and 2015, 17 studies reported MRSA skin and soft tissue infections (SSTIs), with four case reports of MRSA non-SSTI (necrotizing pneumonias, brain abscess, and epiduritis). Significant associations with MRSA SSTI were found: MRSA colonization, previous skin infection, sharing soap or personal items, SSTI presenting as an abscess or furuncle, younger age, non-Caucasian, overweight, communal laundering, infrequent handwashing, lower hygiene score. RECOMMENDATIONS: early identification, isolation, and treatment of skin infections at admission; education on maintaining skin integrity and presenting early with skin infections; increasing hygiene by not sharing items and encouraging handwashing; improved handling and disinfection of communal laundering; influenza vaccination for all prisoners and staff; and population-based longitudinal studies including younger detainees.

Entities:  

Keywords:  MRSA; SSTI; correctional health care; infection; prisons

Mesh:

Year:  2018        PMID: 29661109     DOI: 10.1177/1078345818765271

Source DB:  PubMed          Journal:  J Correct Health Care        ISSN: 1078-3458


  7 in total

1.  Nasal microbiota evolution within the congregate setting imposed by military training.

Authors:  Faith C Blum; Jeannette M Whitmire; Jason W Bennett; Patrick M Carey; Michael W Ellis; Caroline E English; Natasha N Law; David R Tribble; Eugene V Millar; D Scott Merrell
Journal:  Sci Rep       Date:  2022-07-07       Impact factor: 4.996

2.  5-Arylideneimidazolones with Amine at Position 3 as Potential Antibiotic Adjuvants against Multidrug Resistant Bacteria.

Authors:  Aneta Kaczor; Karolina Witek; Sabina Podlewska; Joanna Czekajewska; Annamaria Lubelska; Ewa Żesławska; Wojciech Nitek; Gniewomir Latacz; Sandrine Alibert; Jean-Marie Pagès; Elżbieta Karczewska; Katarzyna Kieć-Kononowicz; Jadwiga Handzlik
Journal:  Molecules       Date:  2019-01-26       Impact factor: 4.411

3.  Antibacterial Activity of Arbutus pavarii Pamp against Methicillin-Resistant Staphylococcus aureus (MRSA) and UHPLC-MS/MS Profile of the Bioactive Fraction.

Authors:  Nawal Buzgaia; Tahani Awin; Fakhri Elabbar; Khaled Abdusalam; Soo Yee Lee; Yaya Rukayadi; Faridah Abas; Khozirah Shaari
Journal:  Plants (Basel)       Date:  2020-11-11

4.  Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates.

Authors:  Qianxing Wu; Niloofar Sabokroo; Yujie Wang; Marzieh Hashemian; Somayeh Karamollahi; Ebrahim Kouhsari
Journal:  Antimicrob Resist Infect Control       Date:  2021-06-30       Impact factor: 4.887

5.  Wound Dressings Coated with Silver Nanoparticles and Essential Oils for The Management of Wound Infections.

Authors:  Bogdan Stefan Vasile; Alexandra Catalina Birca; Mihaela Carmen Musat; Alina Maria Holban
Journal:  Materials (Basel)       Date:  2020-04-03       Impact factor: 3.623

6.  Rhodomyrtone Accumulates in Bacterial Cell Wall and Cell Membrane and Inhibits the Synthesis of Multiple Cellular Macromolecules in Epidemic Methicillin-Resistant Staphylococcus aureus.

Authors:  Ozioma F Nwabor; Sukanlaya Leejae; Supayang P Voravuthikunchai
Journal:  Antibiotics (Basel)       Date:  2021-05-07

7.  Natural brominated phenoxyphenols kill persistent and biofilm-incorporated cells of MRSA and other pathogenic bacteria.

Authors:  Lasse van Geelen; Farnusch Kaschani; Shabnam S Sazzadeh; Emmanuel T Adeniyi; Dieter Meier; Peter Proksch; Klaus Pfeffer; Markus Kaiser; Thomas R Ioerger; Rainer Kalscheuer
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-16       Impact factor: 4.813

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.